- Home
- SCLX vs DTST Comparison
SCLX vs DTST Comparison
Compare SCLX & DTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- DTST
- Stock Information
- Founded
- SCLX 2011
- DTST 2001
- Country
- SCLX United States
- DTST United States
- Employees
- SCLX N/A
- DTST N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- DTST EDP Services
- Sector
- SCLX Health Care
- DTST Technology
- Exchange
- SCLX Nasdaq
- DTST Nasdaq
- Market Cap
- SCLX 35.7M
- DTST 33.4M
- IPO Year
- SCLX N/A
- DTST N/A
- Fundamental
- Price
- SCLX $13.63
- DTST $4.87
- Analyst Decision
- SCLX Strong Buy
- DTST
- Analyst Count
- SCLX 3
- DTST 0
- Target Price
- SCLX $367.50
- DTST N/A
- AVG Volume (30 Days)
- SCLX 225.6K
- DTST 977.3K
- Earning Date
- SCLX 08-12-2025
- DTST 08-13-2025
- Dividend Yield
- SCLX N/A
- DTST N/A
- EPS Growth
- SCLX N/A
- DTST N/A
- EPS
- SCLX N/A
- DTST 0.02
- Revenue
- SCLX $50,710,000.00
- DTST $25,219,312.00
- Revenue This Year
- SCLX $68.30
- DTST $12.57
- Revenue Next Year
- SCLX $124.48
- DTST $9.29
- P/E Ratio
- SCLX N/A
- DTST $199.27
- Revenue Growth
- SCLX 7.79
- DTST N/A
- 52 Week Low
- SCLX $3.60
- DTST $2.93
- 52 Week High
- SCLX $57.75
- DTST $5.57
- Technical
- Relative Strength Index (RSI)
- SCLX 65.59
- DTST 60.24
- Support Level
- SCLX $10.14
- DTST $4.61
- Resistance Level
- SCLX $17.76
- DTST $5.42
- Average True Range (ATR)
- SCLX 1.79
- DTST 0.32
- MACD
- SCLX 0.52
- DTST 0.00
- Stochastic Oscillator
- SCLX 57.45
- DTST 65.55
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.